Challenges to targeting epidermal growth factor receptor in glioblastoma: escape mechanisms and combinatorial treatment strategies
about
Bi-specific molecule against EGFR and death receptors simultaneously targets proliferation and death pathways in tumorsIn vitro antineoplastic effects of brivaracetam and lacosamide on human glioma cells.Therapeutic control and resistance of the EGFR-driven signaling network in glioblastoma.Microglia Activate Migration of Glioma Cells through a Pyk2 Intracellular Pathway.A wide spectrum of EGFR mutations in glioblastoma is detected by a single clinical oncology targeted next-generation sequencing panelEpidermal growth factor receptor targeting and challenges in glioblastoma.Inhibition of glioblastoma cell proliferation, migration and invasion by the proteasome antagonist carfilzomib.Inhibition of cell proliferation, migration and invasion by a glioma-targeted fusion protein combining the p53 C terminus and MDM2-binding domain.EGFR as a Target for Glioblastoma Treatment: An Unfulfilled Promise.Protein residues that control the reaction trajectory in S-adenosylmethionine radical enzymes: mutagenesis of asparagine 153 and aspartate 155 in Escherichia coli biotin synthase.Epidermal growth factor receptor activity is elevated in glioma cancer stem cells and is required to maintain chemotherapy and radiation resistance.3D Mathematical Modeling of Glioblastoma Suggests That Transdifferentiated Vascular Endothelial Cells Mediate Resistance to Current Standard-of-Care Therapy.COX-2/sEH dual inhibitor PTUPB suppresses glioblastoma growth by targeting epidermal growth factor receptor and hyaluronan mediated motility receptor.Spatially graded hydrogels for preclinical testing of glioblastoma anticancer therapeutics.Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies.Connexin 43 C-terminus directly inhibits the hyperphosphorylation of Akt/ERK through protein-protein interactions in glioblastoma
P2860
Q33753135-61146E41-53D0-4D2D-8E40-E2AC38013352Q33768138-2E2D179E-B860-4EC5-A297-FBD0E06D94FEQ35341639-27932013-1AEA-4728-8C42-AC204A0143F5Q35670813-43954CBA-FE5F-4C75-89B1-7F61335E7F57Q35963284-EA4A02FE-6795-464D-8856-580D50573E18Q36977684-4AC3B61F-763E-4DAE-A9B9-30961376D874Q38776733-3787261F-0055-4263-9B87-7F54575A8685Q38796979-C77FD858-D5F6-4A95-8882-481868F63547Q40089704-1063ACB6-DC5C-4FB6-A589-0C9E9CEE8C0CQ40235325-60B070FE-1914-4938-AC16-1CC6C393C213Q42700778-A93C7383-4A6F-413B-9DAA-3B74948BD61EQ46025187-69B847E0-AC24-4B2F-93D3-4ADF994607A4Q46353205-26517AF2-17F8-42EC-81C7-332A9274C757Q47259620-29FF9ADD-A47C-4CA5-834B-647E8C3CCBC8Q50100856-4A87745D-708B-4DB2-BF8E-2FAAC78ACE62Q58792718-C817F191-F5E7-40FB-BD9C-E7D81E396AC3
P2860
Challenges to targeting epidermal growth factor receptor in glioblastoma: escape mechanisms and combinatorial treatment strategies
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Challenges to targeting epider ...... inatorial treatment strategies
@ast
Challenges to targeting epider ...... inatorial treatment strategies
@en
Challenges to targeting epider ...... inatorial treatment strategies
@nl
type
label
Challenges to targeting epider ...... inatorial treatment strategies
@ast
Challenges to targeting epider ...... inatorial treatment strategies
@en
Challenges to targeting epider ...... inatorial treatment strategies
@nl
prefLabel
Challenges to targeting epider ...... inatorial treatment strategies
@ast
Challenges to targeting epider ...... inatorial treatment strategies
@en
Challenges to targeting epider ...... inatorial treatment strategies
@nl
P2860
P356
P1433
P1476
Challenges to targeting epider ...... inatorial treatment strategies
@en
P2093
P2860
P304
P356
10.1093/NEUONC/NOU222
P407
P478
16 Suppl 8
P577
2014-10-01T00:00:00Z